Colard Elyse, Delcourt Sarkis, Padovani Laetitia, Thureau Sébastien, Dumouchel Arthur, Gouel Pierrick, Lequesne Justine, Ara Bardia Farman, Vera Pierre, Taïeb David, Gardin Isabelle, Barbolosi Dominique, Hapdey Sébastien
LITIS-QuantIF-EA4108, University of Rouen, Rouen, France.
Department of Nuclear Medicine, La Timone University Hospital, Marseille, France.
EJNMMI Res. 2018 Nov 15;8(1):99. doi: 10.1186/s13550-018-0454-9.
In FDG-PET, SUV images are hampered by large potential biases. Our aim was to develop an alternative method (ParaPET) to generate 3D kinetic parametric FDG-PET images easy to perform in clinical oncology.
The key points of our method are the use of a new error model of PET measurement extracted from a late dynamic PET acquisition of 15 min, centered over the lesion and an image-derived input function (IDIF). The 15-min acquisition is reconstructed to obtain five images of FDG mean activity concentration and images of its variance to model errors of PET measurement. Our approach is carried out on each voxel to derive 3D kinetic parameter images. ParaPET was evaluated and compared to Patlak analysis as a reference. Hunter and Barbolosi methods (Barbolosi-Bl: with blood samples or Barbolosi-Im: with IDIF) were also investigated and compared to Patlak. Our evaluation was carried on K index, the net influx rate and its maximum value in the lesion (K).
This parameter was obtained from 41 non-small cell lung cancer lesions associated with 4 to 5 blood samples per patient, required for the Patlak analysis. Compare to Patlak, the median relative difference and associated range (median; [min;max]) in K estimates were not statistically significant (Wilcoxon test) for ParaPET (- 3.0%; [- 31.9%; 47.3%]; p = 0.08) but statistically significant for Barbolosi-Bl (- 8.0%; [- 30.8%; 53.7%]; p = 0.001), Barbolosi-Im (- 7.9%; [- 38.4%; 30.6%]; p = 0.007) or Hunter (32.8%; [- 14.6%; 132.2%]; p < 10). In the Bland-Altman plots, the ratios between the four methods and Patlak are not dependent of the K magnitude, except for Hunter. The 95% limits of agreement are comparable for ParaPET (34.7%), Barbolosi-Bl (30.1%) and Barbolosi-Im (30.8%), lower to Hunter (81.1%). In the 25 lesions imaged before and during the radio-chemotherapy, the decrease in the FDG uptake (ΔSUV or ΔK) is statistically more important (p < 0.02, Wilcoxon one-tailed test) when estimated from the K images than from the SUV images (additional median variation of - 2.3% [- 52.6%; + 19.1%] for ΔK compared to ΔSUV).
None of the four methodologies is yet ready to replace the Patlak approach, and further improvements are still required. Nevertheless, ParaPET remains a promising approach, offering a non-invasive alternative to methods based on multiple blood samples and only requiring a late PET acquisition. It allows deriving K values, highly correlated and presenting the lowest relative bias with Patlak estimates, in comparison to the other methods we evaluated. Moreover, ParaPET gives access to quantitative information at the pixel level, which needs to be evaluated in the perspective of radiomic and tumour response.
NCT 02821936 ; May 2016.
在氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)中,标准化摄取值(SUV)图像存在较大的潜在偏差。我们的目的是开发一种替代方法(ParaPET),以生成易于在临床肿瘤学中实施的三维动力学参数FDG-PET图像。
我们方法的关键点是使用从15分钟的晚期动态PET采集中提取的PET测量新误差模型,该采集以病变为中心并采用图像衍生输入函数(IDIF)。对15分钟的采集进行重建,以获得五幅FDG平均活性浓度图像及其方差图像,以模拟PET测量误差。我们的方法在每个体素上进行,以导出三维动力学参数图像。对ParaPET进行了评估,并与作为参考的Patlak分析进行了比较。还研究了Hunter和Barbolosi方法(Barbolosi-Bl:使用血样或Barbolosi-Im:使用IDIF),并与Patlak进行了比较。我们的评估基于K指数、净流入率及其在病变中的最大值(K)。
该参数来自41个非小细胞肺癌病变,每位患者需要4至5份血样用于Patlak分析。与Patlak相比,ParaPET在K估计值中的中位数相对差异及相关范围(中位数;[最小值;最大值])无统计学意义(Wilcoxon检验)(-3.0%;[-31.9%;47.3%];p = 0.08),但Barbolosi-Bl(-8.0%;[-30.8%;53.7%];p = 0.001)、Barbolosi-Im(-7.9%;[-38.4%;30.6%];p = 0.007)或Hunter(32.8%;[-14.6%;132.2%];p < 10)有统计学意义 在Bland-Altman图中,除Hunter外,四种方法与Patlak之间的比率不依赖于K值大小。ParaPET(34.7%)、Barbolosi-Bl(30.1%)和Barbolosi-Im(30.8%)的95%一致性界限相当,低于Hunter(81.1%)。在25个在放化疗前和放化疗期间成像的病变中,从K图像估计时,FDG摄取的降低(ΔSUV或ΔK)在统计学上比从SUV图像估计时更显著(p < 0.02,Wilcoxon单尾检验)(与ΔSUV相比,ΔK的额外中位数变化为-2.3%[-52.6%;+19.1%])。
这四种方法均尚未准备好取代Patlak方法,仍需要进一步改进。然而,ParaPET仍然是一种有前景的方法,它提供了一种基于多个血样的方法的非侵入性替代方案,并且只需要一次晚期PET采集。与我们评估的其他方法相比,它能够得出与Patlak估计高度相关且相对偏差最低的K值。此外,ParaPET能够在像素水平获取定量信息,这需要从放射组学和肿瘤反应的角度进行评估。
NCT 02821936;2016年5月。